Duodopa
Duodopa is a medicine authorised by Swissmedic under authorisation number 57624. The authorisation holder is AbbVie AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 December 2006 and the authorisation is valid without a time limit. ATC code N04BA02 places the medicine in the group Anti-Parkinson drugs.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Duodopa, Gel zur intestinalen Anwendung | B | 21 December 2006 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 7 | Beutel | N04BA02 | 01.08.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Duodopa authorised in Switzerland?
Yes. Duodopa is authorised by Swissmedic under authorisation number 57624, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Duodopa have?
Duodopa is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Duodopa?
The authorisation holder is AbbVie AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.